Cipla

GoApptiv Private Limited, founded in 2015 and based in Thane, India, specializes in developing digital solutions tailored for the healthcare sector. The company offers a comprehensive suite of software aimed at enhancing business tracking, customer relationship management, and patient support. Its platform integrates artificial intelligence and machine learning for advanced data analytics, facilitating better healthcare access, particularly in extra-urban and rural areas of India. GoApptiv's offerings include digital marketing and channel engagement tools for pharmaceutical companies, along with solutions for doctor-patient engagement and healthcare data analytics. By focusing on agile market access and optimizing patient experiences, GoApptiv aims to empower all stakeholders within the healthcare ecosystem.

Wellthy Therapeutics Pvt Ltd is a Mumbai-based company that develops an AI-driven mobile application aimed at assisting patients with type-2 diabetes. The application provides real-time guidance from health coaches, personalized self-management education, and an AI-powered bot for answering patient queries. It also functions as a virtual clinical assistant, enabling doctors to prescribe diabetes care effectively. Key features include a lifestyle tracker, interactive lessons, expert coaching, personalized feedback, and emergency assistance. Wellthy Therapeutics focuses on addressing chronic disease management through clinically validated behavioral interventions and is pioneering the Digital Therapeutics sector in South Asia. The company also publishes The Wellthy Magazine, catering to both patients and healthcare professionals. Established in 2015, Wellthy Therapeutics seeks to improve health equity and patient outcomes by leveraging technology to overcome access and socio-economic barriers to care.

Mirren (Pty) Ltd is a pharmaceutical manufacturer. The company was founded in 1983 and is based in Benoni, South Africa. As of October 22, 2018, Mirren (Pty) Ltd operates as a subsidiary of Cipla Medpro South Africa Limited.

Exelan Pharmaceuticals is a privately held company specializing in the sales and marketing of generic pharmaceuticals, primarily targeting the government and institutional markets. The company partners with a leading global provider of pharmaceutical active ingredients and intermediates, enabling it to offer a diverse range of therapeutic products. Through its strategic alliances and focused approach, Exelan aims to meet the needs of its clients in the pharmaceutical sector.

InvaGen Pharmaceuticals, Inc. is a rapidly growing generic pharmaceutical company based in Hauppauge, New York. The company specializes in the development, manufacturing, marketing, and distribution of high-quality, cost-effective generic prescription medicines. InvaGen focuses on a broad range of therapeutic areas, including cardiovascular, anti-infective, central nervous system disorders, anti-inflammatory conditions, diabetes, and depression. Its product offerings include both immediate-release and modified-release capsules and tablets, catering to the diverse needs of patients. The company operates multiple facilities in Hauppauge to support its drug product development and commercial operations.

Quality Chemicals Limited is a company based in Kampala, Uganda, that specializes in importing and distributing a wide range of health-related products. It focuses on human health, animal health, and environmental and public health solutions. The company provides veterinary drugs and vaccines, as well as pesticides and pest control equipment, including chemicals for indoor residual spraying, anti-termite treatments, and mosquito nets. In addition to its distribution activities, Quality Chemicals offers pest control services targeting various pests such as termites, mosquitoes, rodents, and bedbugs, along with fumigation services. The company also manufactures anti-HIV and anti-malarial medications. Quality Chemicals Limited was incorporated in 1997 and operates as a subsidiary of Cipla (EU) Limited.

Chase Pharmaceuticals Corporation, established in 2007 and based in Washington, D.C., is a specialty pharmaceutical company dedicated to developing innovative treatments for Alzheimer’s disease and related neurodegenerative disorders. The company focuses on the clinical development of CPC-252, a transdermal formulation intended for the treatment of Alzheimer’s disease and Parkinsonism dementia. Chase Pharmaceuticals aims to bridge advancements in basic neurosciences with the pressing medical needs associated with neuropsychiatric diseases. The company identifies promising drug candidates, enhances their value to prepare for global registration, and collaborates with commercial partners for licensing. Alzheimer’s disease represents a significant unmet medical need, with current treatments offering only marginal symptom improvement and high dropout rates. The founders of Chase have developed a patented combination of established pharmaceuticals that they believe could enhance the symptomatic management of Alzheimer’s disease, which has become a leading cause of death in the U.S. and presents a growing economic burden as the population ages.

Cipla Medpro South Africa, a subsidiary of Cipla India, is among the leading pharmaceutical companies in the country, recognized for producing high-quality medicines at affordable prices. Based in Bellville, the company ranks as one of the largest pharmaceutical firms in South Africa by volume and the third largest by value. With a portfolio exceeding 1,000 products across various therapeutic categories, Cipla Medpro is committed to using advanced technology and innovation to address the healthcare needs of patients. The company emphasizes agile and sustainable growth, focusing on complex generics and expanding its offerings in digital health and healthcare therapies, ultimately striving to enhance the health and well-being of its customers.

Meditab Specialities Pvt. Ltd. engages in manufacturing and packing of pharmaceutical products such as tablets.